Skye Bioscience, Inc.
SKYE· Nasdaq
SKYESkye Bioscience, Inc.
Filed Aug 12, 2016 · 10-Q · 43 days after period end · 0001640334-16-001531
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2012 |
|---|---|---|---|---|
| Net Income | $573.09K | -$2.06M | -$142.92K | -$381.00 |
| EPS Diluted | $0.03 | -$0.13 | -$0.02 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 12, 2016 · 43 d after period end
